- A $4.87 million multistate settlement has been reached with GS Labs regarding claims that the company overcharged patients and failed to deliver timely COVID-19 test results from 2020 through 2022.
- The multistate coalition investigated claims of false advertising, delayed test results, and charging high administrative fees despite advertising that patients without insurance would not encounter out of pocket costs.
- The settlement requires GS Labs to pay $3.6 million in restitution to patients, including $1.8 million for cash paying patients overcharged for tests, $1.7 million for patients that were charged administrative fees, and $33,692 for cash paying patients that did not receive test results within 3 days. Additionally, the company must pay $1.25 million to the multistate coalition. The multistate coalition will oversee an online restitution mechanism that is fully funded and administered by GS Labs.